Economic Evaluation of Newborn Screening for Severe Combined Immunodeficiency
Evidence on the cost-effectiveness of newborn screening (NBS) for severe combined immunodeficiency (SCID) in the Australian policy context is lacking. In this study, a pilot population-based screening program in Australia was used to model the cost-effectiveness of NBS for SCID from the government p...
Main Authors: | Sophy T. F. Shih, Elena Keller, Veronica Wiley, Melanie Wong, Michelle A. Farrar, Georgina M. Chambers |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | International Journal of Neonatal Screening |
Subjects: | |
Online Access: | https://www.mdpi.com/2409-515X/8/3/44 |
Similar Items
-
Modelling the Cost-Effectiveness and Budget Impact of a Newborn Screening Program for Spinal Muscular Atrophy and Severe Combined Immunodeficiency
by: Sophy T. F. Shih, et al.
Published: (2022-07-01) -
Development of a Population-Based Newborn Screening Method for Severe Combined Immunodeficiency in Manitoba, Canada
by: J. Robert Thompson, et al.
Published: (2018-06-01) -
A Cost-Effectiveness Analysis of Newborn Screening for Severe Combined Immunodeficiency in the UK
by: Alice Bessey, et al.
Published: (2019-08-01) -
Newborn Screening for SCID and Other Severe Primary Immunodeficiency in the Polish-German Transborder Area: Experience From the First 14 Months of Collaboration
by: Maria Giżewska, et al.
Published: (2020-10-01) -
Postnatal corticosteroid treatment as a risk factor for false positivity in severe combined immunodeficiency newborn screening
by: Po-Sung Chen, et al.
Published: (2023-08-01)